سعر تريسيبا Tresiba‏ 100وحدة دولية/مل فليكستاتش قلم معبأ للحقن 2026

Tresiba 100 units/ml FlexTouch pre-filled pen containing insulin degludec, an ultra-long-acting basal insulin by Novo Nordisk.

• Hypoglycemia, allergic reactions, injection-site reactions, lipodystrophy/localized cutaneous amyloidosis, pruritus, rash, edema, weight gain; nasopharyngitis, URTI, headache in trials.International label, same product · DailyMed (U.S. National Library of Medicine)

• During episodes of hypoglycemia; hypersensitivity to insulin degludec or excipients.International label, same product · DailyMed (U.S. National Library of Medicine)

• Never share a pen between patients, even if the needle is changed.International label, same product · DailyMed (U.S. National Library of Medicine)
• Hyperglycemia or hypoglycemia with changes in insulin regimen; make changes under medical supervision.International label, same product · DailyMed (U.S. National Library of Medicine)
• Hypoglycemia is the most common adverse reaction and may be life-threatening.International label, same product · DailyMed (U.S. National Library of Medicine)

• Antidiabetic agents, ACE inhibitors, ARBs, disopyramide, fibrates, fluoxetine, MAO inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogues (e.g. octreotide), sulfonamide antibiotics, GLP-1 agonists, DPP-4 and SGLT-2 inhibitorsMay increase risk of hypoglycemia; dose reduction and glucose monitoring may be needed.DailyMed (U.S. National Library of Medicine)
• Atypical antipsychotics, corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens, protease inhibitors, somatropin, sympathomimetics, thyroid hormonesMay decrease the blood-glucose-lowering effect; dose increase may be needed.DailyMed (U.S. National Library of Medicine)
• Alcohol, beta-blockers, clonidine, lithium salts, pentamidineMay increase or decrease the glucose-lowering effect.DailyMed (U.S. National Library of Medicine)

• Available data from a randomized trial in pregnant women with type 1 diabetes and observational data have not identified a drug-associated risk of major birth defects or miscarriage; poorly controlled diabetes carries maternal and fetal risks.International label, same product · DailyMed (U.S. National Library of Medicine)
• No data on presence in human milk or effects on breastfed infants; insulin degludec is present in rat milk.International label, same product · DailyMed (U.S. National Library of Medicine)